Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Pediatr Urol ; 13(1): 67.e1-67.e6, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28087230

RESUMEN

INTRODUCTION: It has become clear that obesity is associated with a variety of infectious diseases, including urinary tract infection (UTI) and renal scarring. OBJECTIVE: The aim of this study was to evaluate the association between obesity and the degree of febrile UTI (fUTI) and renal scarring in children with vesicoureteral reflux (VUR), and to stratify the results into obesity subcategories. STUDY DESIGN: A total of 186 patients were diagnosed with VUR between January 2002 and December 2008. This study retrospectively reviewed the medical records of 72 children with primary VUR who had recurrent fUTI (more than twice). Overweight or obese status of the patients aged <2 years was defined using weight-for-length (WFL) measurements. For 2-5 year old children, body mass index (BMI) percentile-for-age was used. They were divided into three groups as follows; standard (<85%), overweight (85-95%), and obese (≥95%). The following clinical variables were compared: age at diagnosis of primary VUR (months), sex, VUR grade, hydronephrosis grade, presence of renal scarring, surgical treatment, and degree of inflammation during fUTI. RESULTS: In the overweight and obese groups, VUR was diagnosed at a young age (P = 0.05), the degree of renal scarring was more severe (P = 0.006), and serum white blood cell count, C-reactive protein, and erythrocyte sedimentation rate (ESR) levels were significantly higher (P < 0.001, P < 0.001, and P < 0.001, respectively). Abnormal focal dimercaptosuccinic acid (DMSA) defects were present in 25 of the 72 children (35%). Cortical defects occurred more frequently in children with obesity, and they were associated with a higher grade of reflux and serum ESR levels (P = 0.007, P = 0.042, and P = 0.021, respectively). Among these risk factors, high-grade VUR (OR = 9.93, 95% CI = 1.13-86.71), and being overweight and obese (OR = 5.26, 95% CI = 1.75-15.82) were associated with increased renal scarring. However, ESR was not associated with renal scarring (OR = 1.01, 95% CI = 0.95-1.07). DISCUSSION: The relationships between obesity and UTI are controversial. Some studies have shown positive results; however, other studies have shown opposite results. The main limitations of this study were the retrospective data collection via electronic medical records, and the small number of subjects. CONCLUSIONS: This study showed that obesity in patients with VUR has an effect on fUTI and renal scar formation. If the patients with VUR have obesity, close follow-up should be performed, and VUR patients should be started on a weight-loss program, which could reduce the number of patients with chronic kidney disease in the future.


Asunto(s)
Cicatriz/epidemiología , Fiebre/fisiopatología , Hidronefrosis/epidemiología , Obesidad/epidemiología , Infecciones Urinarias/epidemiología , Reflujo Vesicoureteral/epidemiología , Factores de Edad , Análisis Químico de la Sangre , Proteína C-Reactiva/análisis , Niño , Preescolar , Cicatriz/patología , Comorbilidad , Intervalos de Confianza , Bases de Datos Factuales , Femenino , Humanos , Hidronefrosis/diagnóstico , Incidencia , Recuento de Leucocitos , Masculino , Obesidad/diagnóstico , Oportunidad Relativa , Pronóstico , Estudios Retrospectivos , Factores de Riesgo , Índice de Severidad de la Enfermedad , Factores Sexuales , Infecciones Urinarias/diagnóstico , Reflujo Vesicoureteral/diagnóstico
2.
Ann Oncol ; 23(8): 1992-1998, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22700992

RESUMEN

BACKGROUND: Cancer patients are at high risk for skin problems because rapidly proliferating skin cells are susceptible to anticancer therapies. However, the effects of daily skin care habits on development of skin problems in cancer patients have rarely been studied. PATIENTS AND METHODS: We conducted a survey of daily skin care habits and the presence of skin problems in 866 cancer patients. RESULTS: Hot water bath>1 h significantly increased the risk of definite eruptions [odds ratio (OR) 4.09] and the risk of itching or pain on the skin (OR 1.73). Diligent use of moisturizers did not decrease the risk of definite eruptions and symptoms, and daily bathing, scrubbing off the skin while bathing, and sun protection did not influence the risk of definite eruptions and symptoms. Subgroup analysis of 183 breast cancer patients showed results similar to the total results, including that hot water bath>1 h significantly increased the risk of definite eruptions (OR 3.41). CONCLUSIONS: Being a cross-sectional study, our study could not prove causality. However, at the present stage of knowledge, avoidance of hot water baths of protracted duration should be first emphasized in patient education to prevent skin problems in cancer patients.


Asunto(s)
Neoplasias/terapia , Cuidados de la Piel/métodos , Enfermedades de la Piel/prevención & control , Antineoplásicos/efectos adversos , Baños , Neoplasias de la Mama/complicaciones , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/terapia , Estudios Transversales , Femenino , Conductas Relacionadas con la Salud , Conocimientos, Actitudes y Práctica en Salud , Humanos , Masculino , Neoplasias/complicaciones , Neoplasias/tratamiento farmacológico , Educación del Paciente como Asunto/métodos , Enfermedades de la Piel/inducido químicamente , Enfermedades de la Piel/etiología , Encuestas y Cuestionarios
4.
Korean J Intern Med ; 5(1): 79-82, 1990 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-2176820

RESUMEN

Malignant fibrous histiocytoma (MFM) is among the most common soft tissue sarcoma of adults, but primary MFH of the lung is very rare. We report a case of primary pulmonary MFH associated with pulmonary artery obstruction.


Asunto(s)
Arteriopatías Oclusivas/etiología , Histiocitoma Fibroso Benigno/complicaciones , Neoplasias Pulmonares/complicaciones , Arteria Pulmonar , Adulto , Femenino , Histiocitoma Fibroso Benigno/patología , Humanos , Neoplasias Pulmonares/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA